scorecardresearch
Add as a preferred source on Google
Friday, March 27, 2026
TopicAbbVie's Humira

Topic: AbbVie's Humira

Lucrative drugs like Viagra, Humira to lose patents but Indian pharma unlikely to gain

Himani Chandna -
Indian pharma companies, which have dominated the world’s generic medicines market, are now hampered by Trump’s policies & lack of expertise in biologics.

Nobel 2018 for medicine & chemistry is great news for science, but probably not patients

Max Nisen -
The pharma industry needs to do a better job of grappling with how success tends to bring out its worst instincts.

On Camera

YourTurn

Opinion

Mamata is the architect of her own troubles. West Bengal won’t be fixed, even if she loses

R Jagannathan -
By confronting everyone who comes in her way, even the Election Commission or crime-fighting agencies like the ED, Mamata Banerjee has shown that for her, everything is personal.

Why Bagher Ghalibaf and Abbas Araghchi are the most crucial negotiators in Iran war

India needs to change how it spends on social sector. Fund outcomes instead

Economy

India’s strategic oil reserves tell a tale of structural constraints & stalled expansion. Here’s why

+TFP Udit Bubna -
India’s oil reserves, which can last just 74-75 days, are much less than other major economies. Japan, for instance, holds reserves for 254 days.

Defence

India-Japan to finalise deal to co-develop & co-produce UNICORN mast ‘soon’, says Japanese envoy

Keshav Padmanabhan -
The countries signed a memorandum for co-development of UNICORN masts in November 2024. India has been second Asian nation to have such an agreement with Tokyo, after Philippines.

National Interest

The Vishwaguru delusion, mine vs yours, is ruining our view of the world

Shekhar Gupta -
One side thinks India is punching way above its weight. The other thinks Modi has undermined India and it punches below its strength. Both are wrong.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.